Good evening :)
Place Order
Add to Watchlist

Sotac Pharmaceuticals Ltd

SOTAC

Sotac Pharmaceuticals Ltd

SOTAC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹138 cr, stock is ranked 2,753
High RiskStock is 6.00x as volatile as Nifty
125.000.00% (+0.00)
125.000.00% (+0.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹138 cr, stock is ranked 2,753
High RiskStock is 6.00x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹138 cr, stock is ranked 2,753
High RiskStock is 6.00x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
30.762.80
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.446.570.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The Company specializes in the manufacturing of a range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-Lactam syrup, and external preparations.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2023FY 2024TTM
Total Revenue77.83104.32106.45
Raw Materialssubtract61.6880.3796.60
Power & Fuel Costsubtract1.371.98
Employee Costsubtract2.582.05
Selling & Administrative Expensessubtract4.234.39
Operating & Other expensessubtract-0.276.72
Depreciation/Amortizationsubtract2.283.103.20
Interest & Other Itemssubtract2.041.742.36
Taxes & Other Itemssubtract1.05-0.31-0.20
EPS3.574.484.06
DPS0.000.00
Payout ratio0.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Sotac Pharmaceuticals Ltd32.262.80
Sun Pharmaceutical Industries Ltd46.316.610.73%
Cipla Ltd30.404.670.84%
Torrent Pharmaceuticals Ltd65.4215.810.87%

Price Comparison

Compare SOTAC with any stock or ETF
Compare SOTAC with any stock or ETF
SOTAC
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding72.85%0.00%0.00%8.99%18.16%

Apr 2023

Sep 2023

Mar 2024

Shareholding History

AprSepMar12.88%8.51%8.99%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

SOTAC has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Sotac Pharmaceuticals schedules board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 2024Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Sotac Pharmaceuticals AGM scheduled

Sotac Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Sotac Pharmaceuticals consolidated net profit rises 34.26% in the June 2024 quarter

Net profit of Sotac Pharmaceuticals rose 34.26% to Rs 1.45 crore in the quarter ended June 2024 as against Rs 1.08 crore during the previous quarter ended June 2023. Sales rose 1.12% to Rs 25.25 crore in the quarter ended June 2024 as against Rs 24.97 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales25.2524.97 1 OPM %8.759.37 - PBDT2.052.11 -3 PBT1.301.50 -13 NP1.451.08 34 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Sotac Pharmaceuticals to conduct board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live